Rejected at 12:20 a.m. Nov, 01, 2023 ] by dollajas
Author: alexanderchang1
Related Note: 1495738313876
Rationale for change

Saw this card for the first time, and the central nervous system tumor line instantly gave away it was BBB. I think this is a better card for learning the information without giving away the answer.

Rejection reason

this card is not that HY and we are okay with it being as easy as it is

Text Text
Extra
- Including glioblastoma multiforme

- Because they can penetrate the blood-brain barrier, worry about CNS side effects (convulsions, dizziness, ataxia)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
This also leads to side effects such as ataxia, dizziness, headaches
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::13_Alkylating_agents::*Nitrosureas #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::11_Busulfan_Cyclophosphamide_Ifosfamide_Nitorsureas !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::09_Nitrosoureas #AK_Step1_v12::#Bootcamp::Neurology::19_Adult_Primary_Brain_Tumors::02_Glioblastoma_Multiforme #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::01_Alkylating_Agents::zanki_extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#B&B::10_Neuro::05_OtherTopics::12_CNS_Malignancy::Extra #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::02_Alkylating_Agents